Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
暂无分享,去创建一个
Jing Zhang | Paulina Kolasinska-Zwierz | P. Kolasinska-Zwierz | J. Breed | J. Debreczeni | R. Minter | T. Rabbitts | R. Overman | C. Phillips | Sandrine Guillard | Jason Breed | Sandrine Guillard | Judit Debreczeni | Nicolas Bery | Rose Marwood | Jon Tart | Ross Overman | Pawel Stocki | Bina Mistry | Christopher Phillips | Terence Rabbitts | Ronald Jackson | Ralph Minter | Ronald Jackson | N. Bery | R. Marwood | J. Tart | P. Stocki | Jing Zhang | Bina Mistry | N. Béry
[1] Roger L. Williams,et al. Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS , 2007, The EMBO journal.
[2] J. Griffiths,et al. Absolute Quantification of Endogenous Ras Isoform Abundance , 2015, PloS one.
[3] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[4] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[5] H. Kaufman,et al. Oncolytic viruses: a new class of immunotherapy drugs , 2015, Nature Reviews Drug Discovery.
[6] Mohammad Reza Ahmadian,et al. Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras , 1997, Nature Structural Biology.
[7] A. Plückthun,et al. Efficient cell-specific uptake of binding proteins into the cytoplasm through engineered modular transport systems. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[8] Philip R. Evans,et al. How good are my data and what is the resolution? , 2013, Acta crystallographica. Section D, Biological crystallography.
[9] Norbert Perrimon,et al. Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices , 2015, Proceedings of the National Academy of Sciences.
[10] Kenji Shimizu,et al. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change , 1982, Nature.
[11] Yi Liu,et al. Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. , 2016, Cancer discovery.
[12] Paramjit S. Arora,et al. An Orthosteric Inhibitor of the Ras-Sos Interaction , 2011, Nature chemical biology.
[13] John C. Hunter,et al. Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations , 2015, Molecular Cancer Research.
[14] S. Biocca,et al. Aggresome formation by anti-Ras intracellular scFv fragments. The fate of the antigen-antibody complex. , 2001, European journal of biochemistry.
[15] D. Esposito,et al. Dragging ras back in the ring. , 2014, Cancer cell.
[16] John Kuriyan,et al. The structural basis of the activation of Ras by Sos , 1998, Nature.
[17] T. Rabbitts,et al. Interfering with RAS–effector protein interactions prevent RAS-dependent tumour initiation and causes stop–start control of cancer growth , 2010, Oncogene.
[18] R. Minter,et al. Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy , 2016, Oncotarget.
[19] T. Rabbitts,et al. Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation , 2003, The EMBO journal.
[20] S. Fesik,et al. Drugging the undruggable RAS: Mission Possible? , 2014, Nature Reviews Drug Discovery.
[21] D. Bar-Sagi,et al. RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.
[22] M. Barbacid,et al. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes , 1982, Nature.
[23] S H Kim,et al. Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. , 1992, Science.
[24] A. Plückthun,et al. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases. , 2012, ACS chemical biology.
[25] Yong Zhou,et al. Ras nanoclusters: Versatile lipid-based signaling platforms. , 2015, Biochimica et biophysica acta.
[26] Malcolm Anderson,et al. Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation. , 2015, Journal of medicinal chemistry.
[27] Neal Rosen,et al. Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism , 2016, Science.
[28] Martyn D Winn,et al. Macromolecular TLS refinement in REFMAC at moderate resolutions. , 2003, Methods in enzymology.
[29] B. Pentelute,et al. Delivery of Antibody Mimics into Mammalian Cells via Anthrax Toxin Protective Antigen , 2014, Chembiochem : a European journal of chemical biology.
[30] Robert A. Weinberg,et al. Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.
[31] Marc Therrien,et al. Inhibition of RAS function through targeting an allosteric regulatory site. , 2017, Nature chemical biology.
[32] C. Der,et al. RAS isoforms and mutations in cancer at a glance , 2016, Journal of Cell Science.
[33] W. Kabsch,et al. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.
[34] K. Dutta,et al. A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling , 2016, Cell.
[35] Özlem Türeci,et al. mRNA-based therapeutics — developing a new class of drugs , 2014, Nature Reviews Drug Discovery.
[36] R. Weinberg,et al. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene , 1982, Nature.
[37] I. Mellman,et al. Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity , 2012, Proceedings of the National Academy of Sciences.
[38] A. Wittinghofer,et al. Selective Targeting of the KRAS G12C Mutant: Kicking KRAS When It's Down. , 2016, Cancer cell.
[39] Andreas Plückthun,et al. Structural and functional analysis of phosphorylation-specific binders of the kinase ERK from designed ankyrin repeat protein libraries , 2012, Proceedings of the National Academy of Sciences.
[40] Alfred Wittinghofer,et al. GEFs and GAPs: Critical Elements in the Control of Small G Proteins , 2007, Cell.
[41] Tristan J. Vaughan,et al. Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.
[42] E. Nishida,et al. Dynamics of the Ras/ERK MAPK Cascade as Monitored by Fluorescent Probes* , 2006, Journal of Biological Chemistry.